Trump administration proposes big changes in how prescription drugs are priced

The Trump administration on Thursday proposed bringing transparency to one of the most secretive aspects of drug pricing by ending the widespread practice of rebates to middlemen — an effort to reduce what consumers pay for prescription medicine.